Trade EVO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Evotec SE American Depositary Shares (EVO) is trading at US$1.60, down 4.19% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$685.9M. Over the past 52 weeks, EVO has traded between US$1.57 and US$4.27. On Syfe you can trade EVO with $0 commission and add it to your watchlist.
| Previous close | US$1.67 |
|---|---|
| Market cap | US$685.9M |
| 52-week range | US$1.57 – US$4.27 |
| Volume | 1.36M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Evotec SE American Depositary Shares
Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.
Year: 1999
Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments
Aug 6, 8:30 AM · MT Newswires
Niagen Bioscience, Evotec to Advance Preclinical Development of NB4168
Aug 3, 1:38 PM · MT Newswires
Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40
Jul 16, 10:35 AM · MT Newswires
Stay on top of EVO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
